Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 17, 2023
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
[ Mon, Apr 17th 2023
] - WOPRAI
Ryan Zimmerman Maintained (TMCI) at Strong Buy with Increased Target to $32 on, Apr 17th, 2023
Ryan Zimmerman of BTIG, Maintained "Treace Medical Concepts, Inc." (TMCI) at Strong Buy with Increased Target from $29 to $32 on, Apr 17th, 2023.
Ryan has made no other calls on TMCI in the last 4 months.
There are 2 other peers that have a rating on TMCI. Out of the 2 peers that are also analyzing TMCI, 1 agrees with Ryan's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- George Sellers of "Stephens & Co." Initiated at Hold and Held Target at $26 on, Tuesday, April 11th, 2023
This is the rating of the analyst that currently disagrees with Ryan
- Drew Ranieri of "Morgan Stanley" Maintained at Buy with Increased Target to $30 on, Wednesday, March 8th, 2023
